Singh: Better eLearning and Knowledge Transfer with Web 2.0



To get “the right information to the right person at the right time” is a popular notion in the world of information technology. This used to be a slow, one-way process. Web 2.0 changed all that. Today, consumer sites like del.icio.us, Flickr, and YouTube offer a more “participatory” Web that allows anyone with a computer and browser to contribute content.

On an enterprise level, companies can utilize Web 2.0 to build “knowledge communities” – be it a team or an entire workforce or customer base -- as a way of gaining a performance edge, says Harvey Singh, founder and CEO of the four-year-old Instancy Inc., based in Cary, NC. These communities might be highly structured, as a means to collaboratively author formal learning programs and develop standard operating procedures (SOPs). Or they might be ad hoc, to encourage informal learning via discussion forums and blogs. Ideally, they’re some combination of both.

With the “many-to-many communication” allowed by Web 2.0, says Singh, “the responsibility, or onus, is on all members of a community [or at least those with permission] to share their expertise about a product, business process, or procedure.” Through a repository, experts and skills are searchable by anyone seeking help or mentorship. It’s all about “collective wisdom” and the speed at which it can be tapped.

All that’s needed is the right software and an “information designer” to work with subject matter experts and organize the community in a way that’s best for individual users, says Singh. “We find that a lot of companies have marketing writers or other business process or operations managers who can handle that [task].” Computer programming knowledge is not required.

Linking knowledge to eClinical processes could be of “enormous benefit,” says Singh. The technology can be used to limit the information a person receives to what they need to know via “knowledge portals” tailored to groups of individuals based on their job and learning requirements. Sub-communities, perhaps representing individual clinical trial sites, could be created within these master communities.

Knowledge portals are enabled by search engines like Google that can quickly hunt down every variety of content – whether an individual wants to “look at best practices or learn how to do something,” says Singh. Metadata tags, such as preferred search terms and job functions, get added whenever content gets accessed, so searches become more meaningful to individuals over time.

eLearning can also happen within knowledge communities, says Singh, including sequenced, personalized programs that include an upfront assessment of current knowledge. The same technology can be leveraged for informal learning, which accounts for 90 percent of workplace education.

A knowledge portal might also be the place to go for support while performing a specific task, much as a GPS device is used to guide drivers to their intended destination, says Singh. A study coordinator, for example, might be prompted about how to move through a patient assessment based on responses to certain questions.

On the administrative side, users will ultimately be able to pull existing knowledge from a repository so patient questionnaires can be more rapidly developed. “It could happen through a browser, so patients who have an eDiary could [also] access multimedia information on their medical condition,” says Singh.

Content management plays a pivotal role in terms of assigning people “privileges,” such as the ability to create structured programs and edit or upload certain documents, says Singh. Instancy’s content management system is unique in that it’s newly integrated into a single, Web-based platform that also includes applications for eLearning and building knowledge communities.

To date, applications of Instancy have been used primarily in the sales and marketing arena for product knowledge dissemination, says Singh. “We’re just beginning to combine the [SOPs] with simple eLearning within clinical trial applications.” But there is “tremendous potential” for more meaningful linkages within all eClinical processes that “would reduce time to competency and ultimately reduce errors and increase efficiency.”

Subscribe to Bio-IT World  magazine.

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .